For comments, suggestions
Created with Raphaël 2.1.0 12.07.1994 Opening of the national phase 31.01.1996 Publication of the PCT application (A) 31.10.1997 Publication of the decision of grant (F2) 30.04.1998 Completion of the opposition filing period 31.10.1998 Issuance of patent (G2) 08.12.1998 Valid until 30.04.2005 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent expired


(11)Number of the document861
(21)Number of the application94-0294
(22)Filing date of the application1989.12.08
 Date of filing the request for examination (pe raspunderea solicitantului) 08.12.1989
(71)Name(s) of applicant(s), code of the countryFMC CORPORATION, US;
(72)Name(s) of inventor(s), code of the countryBlaik Phillip HALLING, US; Debra Ann WITKOWSKI, US;
(73)Name(s) of owner(s), code of the countryFMC Corporation, US;
(54)Title of the inventionMethod and farmaceutical composition for mammals tumor cells destruction
(13)Kind-of-document code
G2, BOPI 11/1998
F2, BOPI 10/1997
A, BOPI 01/1996
(51)International Patent Classification A61K 31/41 (2006.01);
(19)CountryUS
(41)Date of publication of the application1996.01.31
(45)Date of publication of patent granting decision:1997.10.31
(47)Date of issuance of patent1998.09.30
(30)Priority285151, 1988.12.12, US; 335007, 1989.04.07, US
(74)Patent attorneyBABAC Alexandru, Str. Miron Costin nr. 15/2, of.19-20, MD-2045, Chişinău, Republica Moldova
(85)Date of introducing the national procedure1994.07.12
(86)International applicationPCT/US1989/005599, 1989.12.08
(87)International publicationWO 1990/06748, 1990.06.28
 Payment for maintenance up to the date1998.12.08
 Date of patent termination1998.12.08
 Date of publication of the termination of patent, with the right of restoration2004.08.31
 Date of publication of the termination of patent, without the right of restoration2005.04.30
(30*)Priority of the former USSR application351331, 1989.05.03, US; 4895765, 1991.06.11, US
Up
/inventions/details/94-0294